Improving productivity in downstream processing

BioPharm International

Volumn 19, Issue 11, 2006, Pages 48-55

  Sofer, Gail ^a   Chirica, Laura C ^b  

^a GE Healthcare Life Sciences   (United States)

^b BIACORE AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RESIN;

CHROMATOGRAPHY; DOWNSTREAM PROCESSING; PLATFORM TECHNOLOGY; PRODUCTIVITY; PROTEIN PURIFICATION; REVIEW; SCALE UP; TECHNOLOGY;

EID: 33751249642     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Farid S. Established bioprocesses for producing antibodies as a basis for future planning. Adv Biochem Engin Biotechnol. 2006;101:1-41.
2. Wurm FM. Production of recombinant therapeutics in cultivated mammalian cells. Nature Biotechnol. 2004;22(11):1393-8.
3. US Food and Drug Administration. Guidance for industry, investigators, and reviewers: exploratory IND studies. 2006 January [cited 2006 October 9, 2006]. Available from: www.fda.gov/CDER/guidance/7086fnl.htm
4. Slaff G. Application of technology platforms to the purification of monoclonal antibodies. BioProcess International Conference; 2005 Apr 12-13; Berlin, Germany.
5. Phillips J, Liu J. Platform analytical approaches to monoclonal antibody development. BioProcess International Conference; 2005 Apr 12-13; Berlin, Germany.
6. Curtis S, Lee K, Blank GS, Brorson K, Xu Y. Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow-through mode. Biotechnology and Bioengineering. 2003;84(6):715-22,
7. Norling L, Lute S, Emery R, Khuu W, Voisard M, Xu Y, et al. Impact of multiple re-use of anion exchange chromatography media on virus removal. J Chromatogr. 2005;1069(1);79-89.
8. Brorson K, Brown J, Hamilton E, Stein KE. Identification of Protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. J Chromatogr A. 2003 Mar 7;989(1):155-63.
9. Grönberg A, Monie E, Murby M, Rodrigo G, Wallby E, Johansson HJ. A strategy for development of a MAb purification platform. BioProcess International European Conference; 2006 Feb 20-23; Prague, Czech Republic.